Basilea reports significant revenue growth from marketed products and pipeline progress for full-year 2019

NEXT STORY
Immunicum AB (publ) Year-End Report 2019
PREV STORY
The Multiplexed Diagnostics Market is expected to grow by USD 9.35 bn during 2020-2024, progressing at a CAGR of 15% during the forecast period
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Flexion Therapeutics Reports First-Quarter 2016 Financial Results

Zilretta™, Flexion’s non-opioid lead drug candidate (also known as FX006), completed pivotal Phase 2b ...

author_avatar
NASDAQ Market News

South Western Sydney PHN selects Allscripts dbMotion™ Solution to deliver integrated care

SYDNEY, Australia, Sept. 06, 2017 (GLOBE NEWSWIRE) -- South Western Sydney PHN (SWSPHN) has ...

author_avatar
NASDAQ Market News

Improved Laboratory Testing with EC4d Can Help Physicians Monitor Patients with Lupus

ALBUQUERQUE, NM and SAN DIEGO, CA, June 12, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics, ...

author_avatar
NASDAQ Market News